Redhill Biopharma
RDHL
12 hedge funds and large institutions have $80.5K invested in Redhill Biopharma in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
9% more funds holding
Funds holding: 11 → 12 (+1)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
22% less capital invested
Capital invested by funds: $103K → $80.5K (-$23K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$100K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$1.4K |
| 3 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$885 |
| 4 |
FMP
Financial Management Professionals
Austin,
Texas
|
+$219 |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
+$14 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$20.3K |
| 2 |
Morgan Stanley
New York
|
-$10.2K |
| 3 |
GI
GAMMA Investing
Foster City,
California
|
-$7.09K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$2.46K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $57.2K | +$100K | +21,512 | New |
|
|
GI
2
GAMMA Investing
Foster City,
California
| $9.49K | -$7.09K | -1,521 | -30% |
|
|
FDCDDQ
3
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $9.01K | – | – | – |
|
|
4
RhumbLine Advisers
Boston,
Massachusetts
| $3.69K | +$885 | +190 | +16% |
|
|
5
Bank of America
Charlotte,
North Carolina
| $806 | +$1.4K | +301 | +15,050% |
|
|
FMP
6
Financial Management Professionals
Austin,
Texas
| $125 | +$219 | +47 | New |
|
7
Group One Trading
Chicago,
Illinois
| $59 | – | – | – |
|
|
8
Morgan Stanley
New York
| $34 | -$10.2K | -2,200 | -99% |
|
|
SS
9
SBI Securities
Tokyo,
Japan
| $13 | +$14 | +3 | +150% |
|
|
10
UBS Group
Zurich,
Switzerland
| $8 | -$20.3K | -4,364 | -100% |
|
|
VWM
11
Vermillion Wealth Management
Rosemount,
Minnesota
| $5 | – | – | – |
|
|
12
Osaic Holdings
Scottsdale,
Arizona
| – | -$2.46K | -396 | Closed |
|
RDHL Hedge Fund Activity: Q1 2025 in Review
12 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q1 2025, worth a combined $80.5K — down 22% from $103K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new RDHL positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $100K. The largest seller was UBS Group, cutting an estimated $20.3K.
- 12 institutional investors held Redhill Biopharma (RDHL) as of Q1 2025, up from 11 in Q4 2024.
- Funds reported $80.5K of Redhill Biopharma stock for Q1 2025, down 22% quarter-over-quarter.
- 2 funds opened new Redhill Biopharma positions in Q1 2025 and 1 closed out, a net change of +1 holder.
- The largest Redhill Biopharma buyer in Q1 2025 was Citadel Advisors, an estimated $100K added.
- The largest Redhill Biopharma seller in Q1 2025 was UBS Group, an estimated $20.3K sold.
Based on aggregated 13F filings for Q1 2025.